Drug shortage
Extended Release · Sun Pharmaceutical Industries, Inc.
FDA drug shortage · Current · updated Apr 4, 2025
Key facts
| Generic name | Extended Release, Methylphenidate Hydrochloride Tablet |
|---|---|
| Proprietary name | Methylphenidate Hydrochloride |
| Company | Sun Pharmaceutical Industries, Inc. |
| Presentation | Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88) |
| Dosage form | Extended Release, Tablet |
| Strength | 54 mg |
| Status | Current |
| Reason for shortage | Discontinuation of the manufacture of the drug |
| Therapeutic category | Psychiatry |
| Package NDCs | 57664-609-88 |
| First posted | Jul 26, 2023 |
| Last updated | Apr 4, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: